BHVN: Biohaven Ltd. Stock

by  •  • Comments Off on BHVN: Biohaven Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,574.32
Enterprise Value ($M) 3,325.92
Book Value ($M) 427.98
Book Value / Share 5.24
Price / Book 8.35
NCAV ($M) 357.21
NCAV / Share 4.37
Price / NCAV 10.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.86

Liquidity (mrq)
Quick Ratio 7.98
Current Ratio 7.98

Balance Sheet (mrq) ($M)
Current Assets 442.45
Assets 513.21
Liabilities 85.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -436.05
Net Income -408.17
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -331.73
Cash from Investing 129.83
Cash from Financing 211.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Point72 Asset Management, L.P. 3.20 -37.14
02-13 13G/A Janus Henderson Group Plc 7.40 29.34
02-13 13G/A Suvretta Capital Management, Llc 5.70 18.81
01-23 13G/A State Street Corp 4.82 -15.69

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-17 162,446 1,040,176 15.62
2024-04-16 297,382 1,955,136 15.21
2024-04-15 742,984 3,401,934 21.84
2024-04-12 206,205 264,227 78.04

(click for more detail)

Similar Companies
ANRO – Alto Neuroscience, Inc. ANVS – Annovis Bio, Inc.
BHC – Bausch Health Companies Inc. BMY – Bristol-Myers Squibb Company
CTLT – Catalent, Inc.


Financial data and stock pages provided by
Fintel.io